237 related articles for article (PubMed ID: 25247000)
1. Ocular toxicity of systemic anticancer chemotherapy.
Omoti AE; Omoti CE
Pharm Pract (Granada); 2006 Apr; 4(2):55-9. PubMed ID: 25247000
[TBL] [Abstract][Full Text] [Related]
2. Ocular toxicity and cancer chemotherapy. A review.
al-Tweigeri T; Nabholtz JM; Mackey JR
Cancer; 1996 Oct; 78(7):1359-73. PubMed ID: 8839540
[TBL] [Abstract][Full Text] [Related]
3. Ocular toxicity of antineoplastic agents.
Fraunfelder FT; Meyer SM
Ophthalmology; 1983 Jan; 90(1):1-3. PubMed ID: 6828303
[TBL] [Abstract][Full Text] [Related]
4. Ocular surface complications of local anticancer drugs for treatment of ocular tumors.
Moon J; Choi SH; Lee MJ; Jo DH; Park UC; Yoon SO; Woo SJ; Oh JY
Ocul Surf; 2021 Jan; 19():16-30. PubMed ID: 33238207
[TBL] [Abstract][Full Text] [Related]
5. Ocular side effects of cancer chemotherapy.
Vizel M; Oster MW
Cancer; 1982 May; 49(10):1999-2002. PubMed ID: 7074524
[TBL] [Abstract][Full Text] [Related]
6. Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders.
Agustoni F; Platania M; Vitali M; Zilembo N; Haspinger E; Sinno V; Gallucci R; de Braud F; Garassino MC
Cancer Treat Rev; 2014 Feb; 40(1):197-203. PubMed ID: 23850197
[TBL] [Abstract][Full Text] [Related]
7. An overview of chemotherapy toxicities.
Peters BG
Top Hosp Pharm Manage; 1994 Jul; 14(2):59-88. PubMed ID: 10136204
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced ocular disorders.
Li J; Tripathi RC; Tripathi BJ
Drug Saf; 2008; 31(2):127-41. PubMed ID: 18217789
[TBL] [Abstract][Full Text] [Related]
9. Ocular and systemic adverse effects of ophthalmic and non ophthalmic medications.
Izazola-Conde C; Zamora-de la Cruz D; Tenorio-Guajardo G
Proc West Pharmacol Soc; 2011; 54():69-72. PubMed ID: 22423585
[TBL] [Abstract][Full Text] [Related]
10. Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics.
Kunkler AL; Binkley EM; Mantopoulos D; Hendershot AJ; Ohr MP; Kendra KL; Davidorf FH; Cebulla CM
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1771-1781. PubMed ID: 31098752
[TBL] [Abstract][Full Text] [Related]
11. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
[TBL] [Abstract][Full Text] [Related]
12. Ocular adverse effects of anti-cancer chemotherapy.
Stoicescu EA; Iancu RC; Popa Cherecheanu A; Iancu G
J Med Life; 2023 Jun; 16(6):818-821. PubMed ID: 37675170
[TBL] [Abstract][Full Text] [Related]
13. Ocular Surface Side Effects of Novel Anticancer Drugs.
Vitiello L; Lixi F; Coco G; Giannaccare G
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254833
[TBL] [Abstract][Full Text] [Related]
14. Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients.
Hazin R; Abuzetun JY; Daoud YJ; Abu-Khalaf MM
Curr Opin Ophthalmol; 2009 Jul; 20(4):308-17. PubMed ID: 19491683
[TBL] [Abstract][Full Text] [Related]
15. Update on ocular complications of systemic cancer chemotherapy.
Schmid KE; Kornek GV; Scheithauer W; Binder S
Surv Ophthalmol; 2006; 51(1):19-40. PubMed ID: 16414359
[TBL] [Abstract][Full Text] [Related]
16. [Ocular disorders of anticancer drugs--ocular side effects].
Kashiwagi H
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1639-44. PubMed ID: 20841924
[TBL] [Abstract][Full Text] [Related]
17. The impact of anticancer drugs on the ocular surface.
Chiang JCB; Zahari I; Markoulli M; Krishnan AV; Park SB; Semmler A; Goldstein D; Edwards K
Ocul Surf; 2020 Jul; 18(3):403-417. PubMed ID: 32344148
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide and/or Anthracyclines Induced Epiphora in Breast Cancer Patients: A Rare Side-effect.
Kalra R; Chavada B; Madhani NR; Purohit B; Tripathi CB
Curr Drug Saf; 2018; 13(1):62-64. PubMed ID: 28933276
[TBL] [Abstract][Full Text] [Related]
19. Ocular toxicity of targeted therapies.
Renouf DJ; Velazquez-Martin JP; Simpson R; Siu LL; Bedard PL
J Clin Oncol; 2012 Sep; 30(26):3277-86. PubMed ID: 22649132
[TBL] [Abstract][Full Text] [Related]
20. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
